DCH DEC 2025

← Back to Main Index

Question Paper Year
Define hypernatremia and enumerate its causes. (DCH 2025/1) 4P12025
How will you approach and manage a 2-year-old child with complaints of multiple episodes of loose stool and serum sodium of 162 mEq/L? (DCH 2025/1) 6P12025
Organophosphate poisoning: Etiopathogenesis. (DCH 2025/1) 3P12025
Organophosphate poisoning: Clinical features. (DCH 2025/1) 3P12025
Organophosphate poisoning: Management. (DCH 2025/1) 4P12025
Septic shock in children: Pathogenesis of septic shock. (DCH 2025/1) 3P12025
Septic shock in children: Clinical features and management of septic shock. (DCH 2025/1) 3+4P12025
Enlist the steps for conducting a meta-analysis. (DCH 2025/1) 5P12025
Types of study designs. (DCH 2025/1) 5P12025
Briefly explain the various thyroid function tests. (DCH 2025/1) 6P12025
Neonatal screening for congenital hypothyroidism. (DCH 2025/1) 4P12025
Briefly discuss the diagnostic criteria and management of pediatric acute respiratory distress syndrome (ARDS). (DCH 2025/1) 5+5P12025
Briefly discuss the definition, diagnostic evaluation and management of late onset neonatal sepsis. (DCH 2025/1) 2+4+4P12025
Describe the calcium metabolism in infants. (DCH 2025/1) 5P12025
Draw the coagulation cascade and highlight the abnormality in hemophilia. (DCH 2025/1) 5P12025
A 6.5-months-old, exclusively breast fed child is brought to the OPD for health check up. How will you guide the mother regarding complementary feeding? (DCH 2025/1) 6P12025
A 6.5-months-old, exclusively breast fed child is brought to the OPD for health check up. Advise for nutritional supplementation in infants as per national guidelines? (DCH 2025/1) 4P12025
Kangaroo mother care (KMC): Key features and eligibility for KMC. (DCH 2025/1) 2+2P12025
Kangaroo mother care (KMC): Positioning, duration and when to stop KMC. (DCH 2025/1) 2+2+2P12025
Importance of balanced nutrition on child health. (DCH 2025/2) 5P22025
Poshan abhiyan. (DCH 2025/2) 5P22025
Pneumococcal vaccine: What are the types? [1] Schedule for administration. [2] Name the diseases against which it provides protection. (DCH 2025/2) 2P22025
IPV vaccine: Vaccine type and storage precautions in vaccine centre and during immunization session. [2.5] Normal IPV vaccination schedule and change in schedule if child presents for the first time for immunization at 18 months. (DCH 2025/2) 2.5P22025
Acute meningitis in children: List the causative organisms. (DCH 2025/2) 2P22025
Acute meningitis in children: Discuss briefly clinical features and diagnosis. (DCH 2025/2) 4P22025
Acute meningitis in children: Management and complications. (DCH 2025/2) 4P22025
Acquired aplastic anemia in children: Enumerate etiology and classification criteria for severity. (DCH 2025/2) 2+3P22025
Acquired aplastic anemia in children: Briefly discuss the management. (DCH 2025/2) 5P22025
Acute glomerulonephritis: Enlist common differential diagnosis. (DCH 2025/2) 5P22025
Acute glomerulonephritis: Briefly discuss its diagnostic evaluation. (DCH 2025/2) 5P22025
Pediatric Hodgkin's lymphoma: Clinical features. (DCH 2025/2) 3P22025
Pediatric Hodgkin's lymphoma: Diagnostic evaluation. (DCH 2025/2) 3P22025
Pediatric Hodgkin's lymphoma: Staging. (DCH 2025/2) 4P22025
Subacute sclerosing panencephalitis (SSPE): Etiopathogenesis. (DCH 2025/2) 3P22025
Subacute sclerosing panencephalitis (SSPE): Clinical features. (DCH 2025/2) 2P22025
Subacute sclerosing panencephalitis (SSPE): Diagnostic evaluation. (DCH 2025/2) 2P22025
Subacute sclerosing panencephalitis (SSPE): Management. (DCH 2025/2) 3P22025
Briefly explain the laboratory and genetic evaluation of a child with Down's phenotype. (DCH 2025/2) 2+3P22025
Enumerate the normal developmental milestones of a 3-year-old child. (DCH 2025/2) 5P22025
Briefly discuss the etiopathogenesis, clinical features and treatment of hemolytic uremic syndrome. (DCH 2025/2) 3+3+4P22025
Define anemia as per WHO criteria and state its incidence in under 5 children in India. (DCH 2025/2) 5P22025
Discuss the salient points of Anemia Mukt Bharat initiative. (DCH 2025/2) 5P22025
International League Against Epilepsy (ILAE) classification and definition of childhood epilepsy syndromes. (DCH 2025/3) 5P32025
Approach to management of a child with squint. (DCH 2025/3) 5P32025
Briefly discuss the following regarding celiac disease: Etiopathogenesis. (DCH 2025/3) 4P32025
Briefly discuss the following regarding celiac disease: Diagnosis and management. (DCH 2025/3) 6P32025
List the diseases covered in vector borne disease control program. (DCH 2025/3) 2P32025
Define complicated malaria. (DCH 2025/3) 2P32025
Management of complicated malaria. (DCH 2025/3) 3P32025
Salient points of National Malaria Control Programme. (DCH 2025/3) 3P32025
Management of bronchiolitis. (DCH 2025/3) 5P32025
What are the causes of leucocoria in a 2 month old child? (DCH 2025/3) 5P32025
Anorexia nervosa. (DCH 2025/3) 5P32025
Prophylaxis in rheumatic fever. (DCH 2025/3) 5P32025
Stevens-Johnson syndrome : Etiology. (DCH 2025/3) 3P32025
Stevens-Johnson syndrome : Clinical features. (DCH 2025/3) 3P32025
Stevens-Johnson syndrome : Management. (DCH 2025/3) 4P32025
Systemic onset juvenile idiopathic arthritis: Clinical presentation. (DCH 2025/3) 2P32025
Systemic onset juvenile idiopathic arthritis: Diagnostic criteria. (DCH 2025/3) 3P32025
Systemic onset juvenile idiopathic arthritis: Treatment. (DCH 2025/3) 3P32025
Systemic onset juvenile idiopathic arthritis: Long term prognosis. (DCH 2025/3) 2P32025
In a child presenting with complaints of polyuria: Enlist the causes. (DCH 2025/3) 3P32025
In a child presenting with complaints of polyuria: Diagnostic evaluation and management of central cause for polyuria. (DCH 2025/3) 7P32025
A 5-year-old boy presents with fever of 2 weeks duration. Enumerate the possible etiologies. (DCH 2025/3) 4P32025
A 5-year-old boy presents with fever of 2 weeks duration. Discuss the approach to diagnosis. (DCH 2025/3) 6P32025
Briefly discuss the following regarding of substance abuse in adolescents: Epidemiology and risk factors in Indian context. (DCH 2025/3) 4P32025
Briefly discuss the following regarding of substance abuse in adolescents: What is CRAFFT? (DCH 2025/3) 3P32025
Briefly discuss the following regarding of substance abuse in adolescents: Enlist conditions classified as new morbidities in child health. (DCH 2025/3) 3P32025